Health system changes that bolster access to disease-modifying treatments for Alzheimer’s disease could reduce the disparities in diagnosis and improve health equity in disease treatment overall, ...

At the end of October, Nice declined to approve this drug for use on the NHS for treating early-stage Alzheimer's disease.

A new blood test that can detect Alzheimer's disease in mere minutes has the potential to revolutionise treatment.

The Alzheimer's Association says more than 122,000 Missourians 65 years and older are battling Alzheimer's Disease, which has ...

Today, Houston is participating in the Alzheimer’s Association’s campaign to raise awareness about Alzheimer’s disease and ...

The medical community remains committed to improving treatment for those living with Alzheimer’s and other forms of dementia.

Alzheimer's disease is characterized by a progressive loss of nerve cells leading to a decline in memory and cognition. A team of researchers at KU Leuven and VIB explored the molecular sequence of ...

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through ...

U.S. drugmaker AbbVie said on Monday it will buy Aliada Therapeutics for $1.4 billion in cash, betting on an experimental ...

Drs Pavan Brahmbhatt and Amit Agarwal discuss best practices for managing amyloid-related imaging abnormalities in patients ...

Lexeo Therapeutics said Wednesday that it received positive data for its Alzheimer's disease treatment, which suggests that higher doses improved results. The clinical-stage genetic medicine company ...

Rensselaer Polytechnic Institute (RPI) has been awarded two grants by the National Institute on Aging (NIA) to train graduate ...